- Home
- SBGI vs CDNA Comparison
SBGI vs CDNA Comparison
Compare SBGI & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBGI
- CDNA
- Stock Information
- Founded
- SBGI 1986
- CDNA 1998
- Country
- SBGI United States
- CDNA United States
- Employees
- SBGI N/A
- CDNA N/A
- Industry
- SBGI Broadcasting
- CDNA Medical Specialities
- Sector
- SBGI Industrials
- CDNA Health Care
- Exchange
- SBGI Nasdaq
- CDNA Nasdaq
- Market Cap
- SBGI 997.6M
- CDNA 1.1B
- IPO Year
- SBGI 1995
- CDNA 2014
- Fundamental
- Price
- SBGI $14.39
- CDNA $17.64
- Analyst Decision
- SBGI Buy
- CDNA Buy
- Analyst Count
- SBGI 5
- CDNA 8
- Target Price
- SBGI $19.30
- CDNA $29.43
- AVG Volume (30 Days)
- SBGI 333.0K
- CDNA 879.7K
- Earning Date
- SBGI 05-07-2025
- CDNA 05-08-2025
- Dividend Yield
- SBGI 6.94%
- CDNA N/A
- EPS Growth
- SBGI N/A
- CDNA N/A
- EPS
- SBGI 4.69
- CDNA 0.93
- Revenue
- SBGI $3,548,000,000.00
- CDNA $333,785,000.00
- Revenue This Year
- SBGI N/A
- CDNA $13.32
- Revenue Next Year
- SBGI $2.53
- CDNA $14.99
- P/E Ratio
- SBGI $3.07
- CDNA $18.96
- Revenue Growth
- SBGI 13.21
- CDNA 19.07
- 52 Week Low
- SBGI $11.13
- CDNA $7.42
- 52 Week High
- SBGI $18.45
- CDNA $34.84
- Technical
- Relative Strength Index (RSI)
- SBGI 48.38
- CDNA 32.15
- Support Level
- SBGI $13.63
- CDNA $17.73
- Resistance Level
- SBGI $15.05
- CDNA $19.03
- Average True Range (ATR)
- SBGI 0.79
- CDNA 1.28
- MACD
- SBGI 0.04
- CDNA -0.36
- Stochastic Oscillator
- SBGI 64.54
- CDNA 2.03
About SBGI Sinclair Inc.
Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their content to pay-TV distributors.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.